XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net Income $ 60,964 $ 70,997
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Gain on sale of business (14,533) 0
Depreciation and amortization 21,217 21,359
Amortization of debt issue costs 289 481
Provision for doubtful accounts 5,863 1,852
Share-based compensation 7,729 8,633
Deferred income taxes (1,565) 1,409
Finance lease interest 70 31
Changes in operating assets and liabilities:    
Accounts receivable 143,774 46,652
Inventories 226,878 (136,257)
Prepaid expenses and other assets (28,163) 39,178
Other non-current assets 6,022 (1,772)
Accounts payable (117,860) (60,717)
Accrued expenses and other liabilities 11,338 (16,780)
Income taxes payable (5,115) 4,426
Net cash provided by (used in) operating activities 316,908 (20,508)
Cash flows from investing activities:    
Capital expenditures (7,285) (6,549)
Proceeds from sale of business, net of cash transferred 17,978 0
Net cash provided by (used in) investing activities 10,693 (6,549)
Cash flows from financing activities:    
Borrowings on revolving credit, net of expenses 1,242,915 1,871,909
Repayments on revolving credit, net of expenses (1,421,895) (1,848,554)
(Repayments) borrowings on long-term debt, net (5,040) 16,527
Repayments on finance lease obligation (585) (612)
Debt issuance costs 0 (1,407)
Exercise of stock options 4,626 853
Taxes paid on settlement of equity awards (2,794) (2,433)
Common stock repurchased (21,168) (10,718)
Net cash (used in) provided by financing activities (203,941) 25,565
Effect of exchange rate changes on cash and cash equivalents (788) 879
Increase (decrease) in cash and cash equivalents 122,872 (613)
Cash and cash equivalents at beginning of period 36,178 37,987
Cash and cash equivalents at end of period $ 159,050 $ 37,374